Semaglutide found to cut major adverse cardiovascular events in people with overweight, obesity
by Elana GotkineSemaglutide reduces cardiovascular events, regardless of baseline glycated hemoglobin (HbA1c), among people with overweight or obesity and established atherosclerotic cardiovascular di
Updated on: July 10,2024
0
Semaglutide found to cut major adverse cardiovascular events in people with overweight, obesity
by Elana GotkineSemaglutide reduces cardiovascular events, regardless of baseline glycated hemoglobin (HbA1c), among people with overweight or obesity and established atherosclerotic cardiovascular di
Updated on:July 10,2024
0